Zedott 10 DT Tablet contains Racecadotril 10 mg as its active ingredient, an effective antisecretory agent used primarily for the treatment of acute diarrhea. Racecadotril acts by inhibiting enkephalinase, an enzyme responsible for the degradation of endogenous enkephalins, thereby reducing excessive intestinal secretion of water and electrolytes without affecting normal intestinal motility. This mechanism helps to decrease stool output and duration of diarrhea, promoting faster recovery. Zedott 10 DT is indicated for use in both adults and children suffering from acute diarrhea of various etiologies, including infectious and non-infectious causes. The tablet is designed as a dispersible tablet, facilitating ease of administration, particularly in pediatric patients or individuals with swallowing difficulties. It is generally well-tolerated, with a low incidence of adverse effects, which may include mild gastrointestinal symptoms such as nausea or abdominal discomfort. Zedott 10 DT should be used alongside appropriate rehydration therapy to prevent dehydration and electrolyte imbalance. Contraindications include hypersensitivity to Racecadotril or any excipients. Caution is advised in patients with chronic diarrhea or underlying gastrointestinal disorders. Always consult a healthcare professional before initiating treatment to ensure appropriate use and dosage.